Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_assertion type Assertion NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_head.
- NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_assertion description "[Significantly increased frequencies of HLA-DR3 (36% vs 5%), HLA-DR7 (9% vs 4%), HLA-DR11 (36% vs 7%) and HLA-DRw53 (23% vs 5%) were observed in SSc-RA compared with RA patients (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_provenance.
- NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_assertion evidence source_evidence_literature NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_provenance.
- NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_assertion SIO_000772 17384178 NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_provenance.
- NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_assertion wasDerivedFrom befree-20140225 NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_provenance.
- NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_assertion wasGeneratedBy ECO_0000203 NP604831.RABd4s_E9Oyt5ILjC6p1eER_pfgCmPlUQ67OxNMGgHxbM130_provenance.